Literature DB >> 26637658

RNF2 E3 or Not to E3: Dual Roles of RNF2 Overexpression in Melanoma.

Joshua C Black1, Johnathan R Whetstine2.   

Abstract

RNF2/RING1B is amplified and overexpressed in numerous tumors and contributes to tumorigenicity; however, the biologic importance is poorly understood. Surprisingly, the role of RNF2 in tumorigenesis and invasion can be separated into catalytically independent and catalytically dependent processes. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26637658      PMCID： PMC4733319          DOI： 10.1158/2159-8290.CD-15-1285

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  10 in total

Review 1.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

2.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes.

Authors:  Kenneth L Scott; Cristina Nogueira; Timothy P Heffernan; Remco van Doorn; Sabin Dhakal; Jason A Hanna; Chengyin Min; Mariela Jaskelioff; Yonghong Xiao; Chang-Jiun Wu; Lisa A Cameron; Samuel R Perry; Rhamy Zeid; Tamar Feinberg; Minjung Kim; George Vande Woude; Scott R Granter; Marcus Bosenberg; Gerald C Chu; Ronald A DePinho; David L Rimm; Lynda Chin
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

Review 3.  Post-translational modifications of the histone variant H2AZ.

Authors:  Ana Sevilla; Olivier Binda
Journal:  Stem Cell Res       Date:  2013-11-15       Impact factor: 2.020

4.  Dual Roles of RNF2 in Melanoma Progression.

Authors:  Kunal Rai; Kadir C Akdemir; Lawrence N Kwong; Petko Fiziev; Chang-Jiun Wu; Emily Z Keung; Sneha Sharma; Neha S Samant; Maura Williams; Jacob B Axelrad; Amiksha Shah; Dong Yang; Elizabeth A Grimm; Michelle C Barton; Denai R Milton; Timothy P Heffernan; James W Horner; Suhendan Ekmekcioglu; Alexander J Lazar; Jason Ernst; Lynda Chin
Journal:  Cancer Discov       Date:  2015-10-08       Impact factor: 39.397

5.  Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.

Authors:  Margarita Sánchez-Beato; Esther Sánchez; Joaquín González-Carreró; Manuel Morente; Ana Díez; Lydia Sánchez-Verde; María Carmen Martín; Juan C Cigudosa; Miguel Vidal; Miguel A Piris
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

6.  Monoubiquitylation of H2A.Z distinguishes its association with euchromatin or facultative heterochromatin.

Authors:  Elizabeth Sarcinella; Philip C Zuzarte; Priscilla N I Lau; Ryan Draker; Peter Cheung
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

Review 7.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

8.  Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma.

Authors:  Chiara Vardabasso; Alexandre Gaspar-Maia; Dan Hasson; Sebastian Pünzeler; David Valle-Garcia; Tobias Straub; Eva C Keilhauer; Thomas Strub; Joanna Dong; Taniya Panda; Chi-Yeh Chung; Jonathan L Yao; Rajendra Singh; Miguel F Segura; Barbara Fontanals-Cirera; Amit Verma; Matthias Mann; Eva Hernando; Sandra B Hake; Emily Bernstein
Journal:  Mol Cell       Date:  2015-06-04       Impact factor: 17.970

9.  PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.

Authors:  Robert S Illingworth; Catherine H Botting; Graeme R Grimes; Wendy A Bickmore; Ragnhild Eskeland
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

10.  TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein.

Authors:  Sanchita Bhatnagar; Claude Gazin; Lynn Chamberlain; Jianhong Ou; Xiaochun Zhu; Jogender S Tushir; Ching-Man Virbasius; Ling Lin; Lihua J Zhu; Narendra Wajapeyee; Michael R Green
Journal:  Nature       Date:  2014-11-24       Impact factor: 49.962
  10 in total
  1 in total

1.  Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma?

Authors:  Łukasz Kuźbicki; Dariusz Lange; Agata Stanek-Widera; Agnieszka Glińska; Barbara W Chwirot
Journal:  Oncotarget       Date:  2018-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.